A comparative study of quinine and artemether in the treatment of severe malaria in Nigerian children

Tropical Journal of Pharmaceutical Research

Volumn 9, Issue 1, 2010, Pages 11-17

  Aguwa, Cletus N ^a   Ukwe, Chinwe V ^a   Adibe, Maxwell O ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

Artemether; Nigerian children; Paediatric; Quinine; Severe malaria

Indexed keywords

ARTEMETHER; QUINIMAX;

ARTICLE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALE; MORTALITY; NIGERIA; PARASITEMIA; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD;

EID: 77149143881     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v9i1.52030     Document Type: Article

References (16)

1. World Health Organisation. WHO Expert Committee on Malaria: Twentieth Report, 1998. Geneva, Switzerland. World Health Organ Tech Rep Ser 2000; 892: i-v: pp 1-74.
2. Muphy GS, Oldfield EC. Falciparum malaria. Infect Dis Clin North Am 1996; 10: 747-755.
3. Murphy SC, Breman JG. Gaps in the childhood malaria burden in Africa: Cerebral malaria, neorological sequelae, anaemia, respiratory distress, hypoglycaemia, and complications of pregnancy. Am J Trop Med Hyg 2001; 64: S57-S67.
4. Pukrittayakamee S, Supanaranond W, Looareesuwan S, Vanijanonta S, White NJ. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans R Soc Trop Med Hyg 1994; 88: 324-327.
5. Hien TT, White NJ. Qinghaosu. Lancet 1993; 341: 603-608.
6. Ministry of Health (May 2005). National Antimalarial Treatment Policy. Abuja- Nigeria; pp. 1-52.
7. World Health Organisation. Severe falciparum malaria. World Health Organisation, Communicable Diseases Cluster. Trans R. Soc. Trop. Med. Hyg. 2000; 94: S1-S90.
8. Simpson D, Reilly P. Paediatric Coma Scale. (Letter to the Editor). Lancet. 1982; 2: 450.
9. Reilly P, Simpson D.A, Sprod R, Thomas L. Assessing the conscious level in infants and young children: a paediatric version of the Glasgow Coma Scale. Child's Nerv Syst 1988; 4: 30-33.
10. White NJ. Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives. Trans R Soc Trop Med Hyg 1994; 88: Suppl 1:S41-S43.
11. Ingrid van den B., Christa K., Sarwatt Al A., François L., Manica B. and Jean-Paul G. Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo. Malaria Journal 2006, 5:113.
12. Salako LA, Walker O, Sowunmi A. Parenteral therapy of moderately severe malaria: comparison of intramuscular artemether and intramuscular sulfadoxine-pyrimethamine. Trans R Soc Trop Med Hyg 1994; 88: 89-91.
13. Nosten F, ter Kuile F, Thwai KL, Maelankirri L, White NJ. Spiramycin does not potentiate quinine treatment of falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 1993; 87:305-306.
14. Roll Back Malaria, World Health Organization and UNICEF. World malaria report 2005. Available at: http://rbm.who.int/wmr2005. (Accessed October 3, 2009)
15. Stepniewska K, Taylor WR, Mayxay M, Price R, Smithuis F, Guthmann JP, Barnes K, Myint HY, Adjuik M, Olliaro P, Pukrittayakamee S, Looareesuwan S, Hien T.T, Farrar J, Nosten F, Day NP, White NJ. In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. Antimicrob Agents Chemother 2004, 48: 4271-4280.
16. Bloland PB. Drug resistance in malaria. WHO/CDS/CSR/DRS Geneva, Switzerland; 2001.